ImmunoGen Inc IMGN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 01/27/23 EST
4.75UNCH (UNCH)
Volume
11,362
Close
4.75quote price arrow up+0.04 (+0.85%)
Volume
1,672,513
52 week range
3.10 - 6.63
Loading...
  • Open4.72
  • Day High4.87
  • Day Low4.70
  • Prev Close4.71
  • 52 Week High6.63
  • 52 Week High Date08/24/22
  • 52 Week Low3.10
  • 52 Week Low Date06/14/22

Key Stats

  • Market Cap1.049B
  • Shares Out220.75M
  • 10 Day Average Volume2.63M
  • Dividend-
  • Dividend Yield-
  • Beta0.87
  • YTD % Change-4.23

KEY STATS

  • Open4.72
  • Day High4.87
  • Day Low4.70
  • Prev Close4.71
  • 52 Week High6.63
  • 52 Week High Date08/24/22
  • 52 Week Low3.10
  • 52 Week Low Date06/14/22
  • Market Cap1.049B
  • Shares Out220.75M
  • 10 Day Average Volume2.63M
  • Dividend-
  • Dividend Yield-
  • Beta0.87
  • YTD % Change-4.23

RATIOS/PROFITABILITY

  • EPS (TTM)-0.82
  • P/E (TTM)-5.83
  • Fwd P/E (NTM)-4.46
  • EBITDA (TTM)-194.071M
  • ROE (TTM)-157.66%
  • Revenue (TTM)95.607M
  • Gross Margin (TTM)76.15%
  • Net Margin (TTM)-210.33%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date02/23/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ImmunoGen Inc

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
ImmunoGen, Inc. is a clinical-stage biotechnology company focused on developing the antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. An ADC with the Company’s technology comprises an antibody that binds to a target found on tumor cells and is conjugated to one of its potent anti-cancer agents as a payload to kill the tumor cell once the ADC has bound to its target. Its product candidates include Mirvetuximab soravtansine (IMGN853), IMGN632, MGC936 and...
Stephen Mccluski
Independent Chairman of the Board
Mark Enyedy J.D.
President, Chief Executive Officer, Director
Renee Lentini
Interim Chief Financial Officer
Address
830 Winter Street
Waltham, MA
02451
United States

Top Peers

SYMBOLLASTCHG%CHG
ENTA
Enanta Pharmaceuticals Inc
52.02+0.51+0.99%
CDMO
Avid Bioservices Inc
16.39+0.39+2.44%
MORF
Morphic Holding Inc
31.85+0.99+3.21%
BBIO
BridgeBio Pharma Inc
9.11+0.26+2.94%
AGEN
Agenus Inc
2.63+0.19+7.79%